Soga T, Nomura S, Kido H, Yamaguchi K, Fukuroi T, Yanabu M, Kokawa T, Yasunaga K
First Department of Internal Medicine, Kansai Medical University.
Rinsho Ketsueki. 1992 Sep;33(9):1121-7.
Flow cytometry was used to detect platelet-associated fibrinogen (PA-Fbg), platelet-associated fibronectin (PA-FN) and platelet-associated thrombospondin (PA-TSP) on the surface membrane of platelets and plasma (P)-TSP in 30 patients with lung cancer (16 case of adenocarcinoma and 14 of squamous cell carcinoma). ELISA was used to analyze beta-TG and PF4. In the lung cancer group, beta-TG and PF4 were higher than those of a normal control group. PA-Fbg values were correlated with beta-TG and PF4 values. Each adhesive protein had a higher value in the patient than in the normal control group, and the degree of the increase was related to the progression of clinical disease stage. In the squamous cell carcinoma group, the P-TSP value was significantly elevated. Platelet size increased as the clinical stage of the disease progressed. These results suggest the following: 1. An increase in PA-Fbg can indicate the presence of activated platelets. 2. In patients with lung cancer, activated platelets appear in the blood, and their numbers increase as the clinical stage of the disease progresses. 3. Differences in histologic type led to differences in binding adhesive protein.
采用流式细胞术检测30例肺癌患者(16例腺癌和14例鳞癌)血小板表面膜上的血小板相关纤维蛋白原(PA-Fbg)、血小板相关纤连蛋白(PA-FN)和血小板相关血小板反应蛋白(PA-TSP)以及血浆(P)-TSP。采用酶联免疫吸附测定法分析β-血小板球蛋白(β-TG)和血小板第4因子(PF4)。肺癌组β-TG和PF4高于正常对照组。PA-Fbg值与β-TG和PF4值相关。各黏附蛋白在患者中的值高于正常对照组,且升高程度与临床疾病分期进展相关。在鳞癌组中,P-TSP值显著升高。血小板大小随疾病临床分期进展而增大。这些结果提示如下:1. PA-Fbg升高可提示存在活化血小板。2. 在肺癌患者中,活化血小板出现在血液中,且其数量随疾病临床分期进展而增加。3. 组织学类型的差异导致黏附蛋白结合的差异。